🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 7 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/06/2017 44,45 45,35 44,10 44,70 +0,68% 2,81% 493.500
31/05/2017 45,60 45,95 43,96 44,40 -2,20% 4,36% 476.200
30/05/2017 45,15 45,90 45,05 45,40 +0,55% 1,88% 410.100
26/05/2017 45,45 45,75 44,65 45,15 -0,66% 2,42% 476.700
25/05/2017 46,50 46,60 45,10 45,45 -1,84% 3,23% 565.800
24/05/2017 47,20 47,45 45,85 46,30 -1,91% 3,39% 555.300
23/05/2017 47,20 47,40 45,60 47,20 +0,43% 3,81% 717.000
22/05/2017 48,35 48,73 47,00 47,00 -2,69% 3,58% 555.800
19/05/2017 48,20 49,38 47,50 48,30 +0,52% 3,90% 589.300
18/05/2017 48,25 48,40 47,00 48,05 -0,31% 2,90% 448.000
17/05/2017 49,75 50,25 48,10 48,20 -4,46% 4,32% 556.600
16/05/2017 51,50 51,60 50,30 50,45 -1,46% 2,52% 347.900
15/05/2017 50,75 51,85 50,40 51,20 -0,97% 2,86% 783.100
12/05/2017 50,90 52,15 50,75 51,70 +1,08% 2,75% 584.800
11/05/2017 48,95 52,48 48,60 51,15 +4,07% 7,93% 1.467.800
10/05/2017 48,65 49,45 48,35 49,15 +0,72% 2,26% 687.400
09/05/2017 47,95 49,00 47,95 48,80 +2,31% 2,19% 908.800
08/05/2017 47,50 48,35 46,85 47,70 -0,31% 3,16% 608.400
05/05/2017 46,65 47,90 45,43 47,85 +2,24% 5,29% 748.200
04/05/2017 45,50 47,65 45,00 46,80 +2,18% 5,82% 1.132.700
03/05/2017 47,80 47,83 45,05 45,80 -4,88% 5,82% 1.522.800
02/05/2017 49,00 49,10 47,25 48,15 -1,53% 3,78% 562.200
01/05/2017 48,60 49,35 47,95 48,90 +0,72% 2,88% 694.900
28/04/2017 48,10 49,25 47,30 48,55 +1,04% 4,05% 941.700
27/04/2017 47,35 48,35 46,25 48,05 +1,59% 4,44% 671.100
26/04/2017 46,40 47,60 46,15 47,30 +2,16% 3,13% 794.200
25/04/2017 46,70 47,50 46,20 46,30 -0,22% 2,78% 468.600
24/04/2017 46,05 46,45 45,25 46,40 +2,65% 2,61% 474.000
21/04/2017 45,60 45,95 44,88 45,20 -1,31% 2,35% 392.200
20/04/2017 45,15 45,93 45,00 45,80 +1,78% 2,06% 347.200